Andrew J. Saxon, M.D.
Professor, Department of Psychiatry and Behavioral Sciences, University of Washington
Director, Addictions Treatment Center, VA Puget Sound Health Care System
Director, Addiction Psychiatry Residency Program, University of Washington
Preceding his entry into psychiatry, Dr. Saxon completed an internal medicine internship and worked for 4 years as an emergency room physician. Subsequent to his general psychiatry residency at the University of Washington, Dr. Saxon has 25 years of experience as a clinical and research addiction psychiatrist. Dr. Saxon is board certified with added qualifications in addiction psychiatry by the American Board of Psychiatry and Neurology. Dr. Saxon serves as one of five National Clinical Experts on office-based treatment of opioid dependence with buprenorphine for the Physician Clinical Suppport System, a national mentoring network for physicians. Dr. Saxon is also the Medical Director of the SAMHSA funded Physician Clinical Support System for Methadone. He sits on the editorial boards of the journals, Drug and Alcohol Dependence and General Hospital Psychiatry.
Dr. Saxon’s current research work involves pharmacotherapies and psychotherapies for alcohol, cocaine, methamphetamine, nicotine, and opioid dependence as well work in co-occurence of substance dependence and posttraumatic stress disorder.
Peer Reviewed Papers
Richard Ries, M.D.
Dr. Richard Ries is Professor of Psychiatry at the University of Washington Medical School in Seattle, Washington. Dr. Ries serves as Associate Director of the University of Washington Addiction Psychiatry Residency Program. He is board certified in Psychiatry and certified in Addiction Medicine by the American Society for Addiction Medicine, and in Addiction Psychiatry (1993) by the American Board of Psychiatry and Neurology. Dr. Ries is Director of Outpatient Psychiatry, Dual Disorder Programs, and the Chemical Dependency Project at Harborview Medical Center. He is director of substance abuse education at the University of Washington Medical School and director of the Division of Addictions for the Department of Psychiatry. He has obtained NIDA sponsored clinical research grants in 1989 and 1997 to evaluate treatment outcome in dual disorders and also helped develop and participate in a NIDA sponsored training videotape (1996) on dual disorders. Dr. Ries was chosen to chair the first official Treatment Improvement Protocol (TIP#9-1994) on dual disorders by the Center for Substance Abuse Treatment and is currently co-chair of the TIP#9 update. In 1999 he became co-editor of the key reference text Principles of Addiction Medicine, published by the American Society of Addiction Medicine.
Richard Ries CV
John S. Baer, Ph.D.
||John S. Baer, Ph.D., is a Research Professor
in the Department of Psychology at the University of Washington in
Seattle, and is currently Director of an Interdisciplinary Fellowship
in Substance Abuse Treatment at the Center of Excellence for Substance
Abuse Treatment and Education at the Veterans Affairs Puget Sound
Health Care System. He is also the Director of Training
for the Washington Node within the National Institute on Drug Abuse’s
Clinical Trials Network at the Alcohol and Drug Abuse Institute at
the University of Washington. Dr. Baer received his doctoral degree
in Clinical Psychology from the University of Oregon in 1986 after
a clinical internship in the Department of Psychiatry and Behavioral
Sciences at the University of Washington. Dr. Baer’s research
and clinical interests focus on the assessment, prevention, treatment,
and relapse of substance use and abuse. He has specialized in
the study of brief interventions for both prevention and treatment
of substance use problems, and has studied adult, young adult, and
adolescent populations. Dr. Baer is the author of over 70 academic
papers and chapters. He has provided professional training workshops
on substance abuse, relapse prevention, early intervention for problem
drinking, and motivational interviewing over many years. Dr.
Baer is the recipient of National Institute of Health research grants
examining etiology of alcohol problems, brief interventions for homeless
adolescents, and most recently for the study of training practitioners
and assessing skills in Motivational Interviewing. He serves on the
editorial boards for the Journal of Studies on Alcohol, Journal
of Substance Abuse Treatment, Journal of Child and Adolescent
Substance Abuse, and Journal of Consulting and Clinical Psychology.
Dr. Baer also maintains a small private clinical practice outside
Ray Hsiao, M.D.
Joseph P. Reoux, M.D.
||Dr. Reoux is an Assistant
Professor in the Department of Psychiatry and Behavioral Sciences.
Primary clinical assignment is as medical director for the inpatient
addiction treatment program, and he provides psychiatric and medical
oversight for the Partial Hospital Program and the Admissions and
Evaluation Clinic for the Addiction Treatment Center. Research interests
include the pharmacotherapy of substance withdrawal and relapse prevention.
In addition, Dr. Reoux has developed protocols for alcohol and opioid
detoxification. Dr. Reoux recently published the first controlled
study of valproate in the treatment of alcohol withdrawal (Reoux,
J.P., Saxon, A.J., Malte, C.A., Sloan, K., & Baer, J.: Divalproex
sodium in alcohol withdrawal: a randomized double-blind placebo controlled
clinical trial. Alcoholism: Clinical and Experimental Research 25:1324-1329,
Christine Yuodelis-Flores, M.D.
||Dr. Yuodelis-Flores is a Clinical Associate Professor in the Department of Psychiatry and Behavioral Sciences. She is board certified in Psychiatry by the American Board of Psychiatry and Neurology (1992), certified by the American Society of Addiction Medicine (2002) and in Addiction Medicine by the American Board of Addiction Medicine (2009). Her primary clinical assignment is at Harborview Mental Health and Addiction Services where she provides supervision for residents or fellows in the Women–Focus Addiction Psychiatry Elective and the Co-occurring Disorder Psychiatry Elective. She also consults at the Madison Clinic and provides supervision for psychiatry residents in the HIV-Focus and Hispanic-Focus and supervises the Internal Medicine residents in the Addiction Medicine Elective. Her research interests include Substance-induced Psychiatric Disorders and associated suicidal behavior, and co-occurring disorders in homeless and HIV populations.
Additional faculty members include: